INVINVNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank38
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
1.37%
↓ 94% vs avg
Percentile
P38
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
23.58%
Historical baseline
PeriodValue
Q3 20251.37%
Q2 2025-2.96%
Q1 202517.10%
Q4 2024110.82%
Q3 202443.59%
Q2 20245.69%
Q1 202441.56%
Q4 2023-4.92%
Q3 20230.00%